Author: Brian Wu, MD candidate, Keck School of Medicine, Los Angeles, USA. DermNet New Zealand Editor in Chief: Hon A/Prof Amanda Oakley, Dermatologist, Hamilton, New Zealand. Copy editor: Maria McGivern/Gus Mitchell. July 2017.
The term plasmapheresis describes a procedure in which blood components (ie, white blood cells, red blood cells, platelets and plasma) are separated through a wide-bore central intravenous line, either via centrifuge or a semipermeable membrane separation technique. It can be repeated every few days on several occasions.
In therapeutic plasmapheresis (also known as plasma exchange) using a centrifuge:
3–6 litres of filtered plasma is discarded over several hours
Red blood cells and replacement fluid (donor plasma or albumin) are returned to the patient.
In comparison, plasmapheresis via a membrane separation technique:
Uses various types of filters
Removes undesired macromolecules
Returns the processed plasma to the patient.
Plasma exchange can also involve:
Transfusion of replacement protein products, such as individual clotting factors
Cytapheresis (the selective removal of blood cells), more specifically erythrocytapheresis (the removal of red cells), leukapheresis (the removal of white cells), or plateletapheresis (the removal of platelets).
What is plasmapheresis used for?
Plasmapheresis removes autoantibodies, immune complexes, complement and non-specific inflammatorymediators. It is primarily used in severe autoimmune or cytotoxic diseases.
It has been used for a variety of haematological, rheumatological, metabolic, dermatological, neurological and renal conditions. Clinical evidence is strongest for the use of plasmapheresis in Guillain–Barrée syndrome, myasthenia gravis, thrombotic thrombocytopenic purpura, Goodpasture syndrome and fulminant Wilson disease.
Plasmapheresis is not often used in dermatology; it is used mainly experimentally for the following disorders:
Bacohn R. IVIG or plasmapheresis for neuromuscular disease: pros and cons. University of Kansas Medical Center, April 2014 (accessed 28 November 2016).
Grebennikov VA, Beliaevskiĭ AD, Kaminskiĭ MIu, Kuzina ZA, Litvinenko TA. [The immunocorrective and detoxifying actions of hemosorption, plasmapheresis and enterosorption in pemphigus]. Vestn Dermatol Venerol 1990; (5): 33–8. Russian. PubMed
Pavenski K, Vandenberghe H, Jakubovic H, Adam DN, Garvey B, Streutker CJ. Plasmapheresis and steroid treatment of levamisole-induced vasculopathy and associated skin necrosis in crack/cocaine users. J Cutan Med Surg 2013; 17: 123–8. DOI: 10.2310/7750.2012.12028. PubMed
Potekaev NS, Kurdina MI, Orlov SL, et al. [Plasmapheresis in dermatology]. Ter Arkh 1991; 63(10): 133–8. Russian. PubMed
Stieglitz E. Plasmapheresis. Medscape. Updated 2016. (accessed 22 November 2016).
Plasmapheresis: effective treatment. Therapeutic apheresis for dermatology. Available at: https://tinyurl.com/yc7qwvnc (accessed 22 November 2016).